By Conjoint Associate Professor Xia Wang

Preprints

Nguyen MTH; Sakamoto Y; Maeda T; Woodward M; Anderson CS; Catiwa J; Yazidjoglou A; Carcel C; Yang M; Wang X, Influence of socioeconomic status on functional outcomes after stroke: a systematic review and meta-analysis, http://dx.doi.org/10.1101/2023.10.09.23296685

Wang X; Ren X; Li Q; Ouyang M; Chen C; Delcourt C; Chen X; Wang J; Robinson T; Arima H; Ma L; Hu X; You C; Li G; Yang J; Lin Y; Billot L; Muñoz-Venturelli P; Martins S; Pontes-Neto OM; Liu L; Chalmers J; Song L; Anderson CS; Investigators TI, Optimizing blood pressure in acute intracerebral hemorrhage: protocol for a prospective individual participant data meta-analysis of the four INTERACT trials, http://dx.doi.org/10.1101/2025.03.03.25323285

Tan Q; He S; Mao F; Deng H; Zheng D; Chen X; Zhou J; Lin Y; Yang J; Wang X, Prior antiplatelet is associated with better outcome for acute ischemic stroke patients treated with endovascular treatment: a prospective cohort study in China, http://dx.doi.org/10.21203/rs.3.rs-4179733/v1

Lin X; Jiang C; Wang Z; Arima H; Wang X; Billot L; Neal B; Rodgers A; Hillis GS; Patel A; Biostat QLM; Dong J; Du X; Ma C; Anderson CS, Statistical Analysis Plan (SAP): A randomized controlled trial of intensive blood pressure control on cardiovascular risk reduction in patients with atrial fibrillation: the CRAFT trial, http://dx.doi.org/10.1101/2025.06.19.25329849

Billot L; Bompoint S; Ouyang M; Xu L; Wang X; Malavera A; Johnson B; Summers D; Khatri P; Muñoz-Venturelli P; Day D; Sui Y; Song L; Zaidi WAW; Thang NH; Delcourt C; Robinson T; Jan S; Lindley RI; Urrutia VC; Anderson CS, Statistical Analysis Plan for the Optimal Post rTpa-Iv Monitoring in Ischemic Stroke Trial (OPTIMIST), http://dx.doi.org/10.1101/2024.12.17.24319094

Lin X; Delfino C; Carcel C; Venturelli PM; Naismith S; Woodward M; Peters R; Wijesuriya N; Law M; Harding IH; Wang X; Leder K; Hutchings O; Skiba M; Stecher X; Zomer E; Zoungas S; Anderson CS, Statistical analysis plan for the STatin TReatment for COVID-19 to Optimise NeuroloGical recovERy (STRONGER) study: a randomised, open label, controlled trial in subjects with persistent neurological symptoms after COVID-19 infection, http://dx.doi.org/10.1101/2025.07.03.25330859

Back to profile page